32 results on '"Moussalli, J."'
Search Results
2. Long term prognostic value of the FibroTest in patients with non-alcoholic-fatty-liver disease (NAFLD), compared to chronic hepatitis C (CHC), B (CHB), and alcoholic liver disease (ALD)
3. Abstract 844: PPARD downregulation in cancer cells suppresses metastases by inhibiting tumor angiogenesis and EMT
4. COL 4-04 - C-EDGE CO-STAR : efficacité de l’elbasvir et du grazoprévir chez les utilisateurs de drogues injectables (UDI) recevant un traitement par agoniste des récepteurs opioïdes
5. P0789 : Effectiveness, safety and cost per SVR in GT4 hepatitis C patients treated with sofosbuvir-based therapies in real clinical practice: A Franco-German experience (SOFEX-4)
6. Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial
7. 487 LONG TERM SURVIVAL OF LIVER FIBROSIS AFTER VIROLOGICAL CURE (SVR) IN HIV–HCV COINFECTED PATIENTS: A WORRISOME LATENT DISEASE?
8. 765 TWELVE-MONTHS ENTECAVIR LONGITUDINAL CHANGES IN LIVER FIBROSIS, ACTIVITY AS PER FibroTest-FibroMax AND LIVER STIFFNESS MEASUREMENTS IN CHRONIC HEPATITIS B. STEATOSIS IMPACT ON FIBROSIS REGRESSION
9. 1333 HCV-GENOFIBROTEST: A COMBINATION OF VIRAL, LIVER AND GENOMIC (IL28B, ITPA, UGT1A1) BIOMARKERS FOR PREDICTING TREATMENT RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C
10. Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: An overview of published trials
11. 10 RESULTS OF A PROOF OF CONCEPT STUDY (C210) OF TELAPREVIR MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 4 HCV PATIENTS
12. 56 LONG-TERM EFFICACY OF ROSIGLITAZONE IN NONALCOHOLIC STEATOHEPATITIS (NASH): RESULTS OF THE EXTENSION PHASE OF THE FLIRT-2 TRIAL
13. Discordance between results of biomarkers of fibrosis shows that it is at least a “ménage à deux”
14. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update
15. FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence
16. Alcool, stéatohépatite métabolique, insulinorésistance et hépatite C
17. Prise en charge des hépatites virales en ville
18. Tratamiento de las hepatitis virales
19. [555] FACTORS IMPROVING MANAGEMENT OF HEPATITIS C IN DRUG USERS. AN EXPERIENCE IN A DRUG ADDICT'S CENTRE
20. [240] APPLICABILITY OF NON-INVASIVE METHODS FOR THE DIAGNOSIS OF LIVER INJURY, LIVER STIFFNESS MEASURES (LSM) OR BIOMARKERS, AND FACTORS ASSOCIATED WITH NON-APPLICABILITY
21. A prospective assessment of an ‘a la carte’ regimen of PEG‐interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers
22. CA28 - Traitement de l’hépatite C chez les malades toxicomanes : expérience au sein d’un CSST
23. CA18 - Analyse prospective de la valeur pronostique du fibrotest dans l’hépatite chronique C
24. CA27 - Observatoire ponts : volonté des soignants et désirs des malades assurent des traitements efficaces des hépatites C chez les toxicomanes
25. Sarcoïdose et traitement par les interférons : Une possible relation de causalité. À propos de cinq observations issues de deux cohortes de 60 et 1 159 patients
26. Impact des traitements antiviraux sur les manifestations extrahépatiques des patients avec hépatite C chronique
27. A short induction regimen of interferon‐α is not effective for treatment of relapse in chronic hepatitis C: a randomized trial
28. Management of hepatitis C
29. Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin
30. CHRONIC LIVER DYSFUNCTION IN HEART TRANSPLANT RECIPIENTS, WITH SPECIAL REFERENCE TO VIRAL B, C, AND NON-A, NON-B, NON-C HEPATITIS
31. Delayed anti-HCV antibody seroconversion in 41 heart transplanted patients with non A non B post transfusion hepatitis
32. High prevalence of viral B hepatitis after heart transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.